- €63.33bn
- €71.64bn
- €21.10bn
Brief: Merck Signs Renewable Energy Contract For South Korea Sites
Novartis could expand direct-to-patient sales in US, CEO says (updated)
Europe Research Roundup: Barclays, L'Oreal, SAP
Europe Research Roundup: Atalaya Mining Copper, BNP Paribas, Tele2
Brief: Merck Publishes Long-Term Efficacy And Safety Data From Phase 3 Defi Trial Of Ogsiveo®
Brief: Merck - Pimicotinib Treatment Demonstrates Deep And Durable Tumor Responses And Continued Improvements In Pain And Function For Patients With Tgct
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Press Digest: Wall Street Journal - October 17
US FDA announces recipients of national priority vouchers (updated)
Merck says it reaches deal with Trump to cut some IVF drug prices (updated)
Trumps says US will slash cost of IVF
Brief: EMD Serono Announces Agreement With U.S. Government To Expand Access To IVF Therapies
Germany's Merck shares slip after 2026 guidance at CMD
Brief: Merck Gives 2026 Outlook In CMD Presentation
Brief: Merck KGaA Targets Mid-Term Annual Organic Sales Growth In Mid Single-Digit Percentage Range
Germany's Merck tweaks mid-term healthcare unit guidance, has 'appetite' for more M&A (updated)
Brief: Merck KGaA CEO In Interview Says We Have Appetite For M&A With Priority On Life Science
Germany's Merck tweaks mid-term healthcare unit guidance
Brief: Merck KGaA - Milliporesigma To Acquire Chromatography Business Of Jsr Life Sciences